Baird Starts Intellia Therapeutics (NTLA) at Neutral

June 2, 2022 4:16 PM EDT
Get Alerts NTLA Hot Sheet
Price: $55.96 +1.21%

Rating Summary:
    24 Buy, 3 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 10 | Down: 4 | New: 31
Join SI Premium – FREE

Baird analyst Jack Allen initiates coverage on Intellia Therapeutics (NASDAQ: NTLA) with a Neutral rating and a price target of $58.00.

For an analyst ratings summary and ratings history on Intellia Therapeutics click here. For more ratings news on Intellia Therapeutics click here.

Shares of Intellia Therapeutics closed at $42.86 yesterday.

You May Also Be Interested In

Related Categories

New Coverage